Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▲ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | -2.230% | -2.907% | -1.284% | 44.074% | 6.370% | 68.750% | 80.769% |
| Merit Medical Systems | -1.360% | -0.685% | 9.023% | -5.229% | 6.618% | 38.095% | 44.394% |
| Novocure Ltd | -1.990% | 11.707% | 12.652% | -76.475% | 7.285% | -89.787% | - |
| Xencor Inc. | -0.890% | 20.856% | 14.141% | -8.130% | 9.709% | -35.244% | - |
| PTC Therapeutics Inc. | -0.700% | -6.623% | 15.574% | -43.600% | 11.905% | -11.321% | -22.389% |
| Ligand Pharmaceuticals | 8.760% | 12.782% | -0.662% | 4.895% | 15.385% | -28.161% | -28.950% |
| Halozyme Therapeutics Inc. | 0.300% | 7.833% | 9.513% | 27.539% | 18.346% | 5.643% | - |
| Blueprint Medicines Corp | -1.180% | -0.502% | 17.629% | 101.260% | 20.024% | 30.221% | - |
| Healthequity Inc. | - | 0.000% | 0.694% | 43.564% | 21.849% | 22.508% | - |
| United Therapeutics | 1.380% | 0.698% | 10.840% | 27.052% | 23.783% | 56.306% | 193.857% |
| Myriad Genetics | 12.820% | 22.222% | 17.021% | 34.146% | 24.294% | -2.222% | -12.281% |
| Fibrogen Inc. | -9.390% | 2.560% | -18.470% | -93.324% | 25.756% | -93.232% | - |
| Medpace Holdings Inc | -0.250% | -0.794% | -2.160% | 89.092% | 28.932% | 176.565% | - |
| Davita Inc. | 0.040% | 2.161% | 3.865% | 41.237% | 35.194% | 21.110% | 181.726% |
| Tandem Diabetes Care Inc | 3.290% | -0.890% | 28.078% | 37.944% | 48.165% | -37.892% | - |
| Agios Pharmaceuticals Inc. | -3.110% | 1.307% | 13.139% | 32.479% | 50.485% | -32.211% | -29.601% |
| Nektar Therapeutics | 4.690% | 11.339% | 34.156% | 139.495% | 227.244% | -89.966% | - |